APC loss induces tumor-elicited inflammation, which leads to the disruption of the intestinal epithelial barrier, activation of IL-23-synthesizing myeloid cells, and expansion of tumor-resident IL-17-producing T lymphocytes, thereby stimulating proliferation of early tumor progenitors and causing adenoma growth [36,39]. Here, IL17A is linked to neoplasm.